You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 14, 2025

Details for Patent: 7,658,944


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,658,944
Title:Solid dosage form comprising a fibrate
Abstract:The invention provides stable, solid dosage forms and pharmaceutical compositions in particulate form comprising a fibrate, for example fenofibrate, dissolved in an non-aqueous vehicle in order to ensure improved bioavailability of the active ingredient upon oral administration relative to known fibrate formulations.
Inventor(s):Per Holm, Tomas Norling
Assignee:Veloxis Pharmaceuticals Inc
Application Number:US10/513,807
Patent Claim Types:
see list of patent claims
Dosage form; Formulation; Composition; Use;
Patent landscape, scope, and claims:

Detailed Analysis of the Scope, Claims, and Patent Landscape for U.S. Patent 7,658,944


Introduction

U.S. Patent No. 7,658,944, granted on February 2, 2010, represents an important intellectual property asset in the pharmaceutical landscape. It pertains to a specific drug formulation, method of use, or a novel compound pertinent to therapeutic avenues. Analyzing its scope, claims, and broader patent landscape offers insights into its exclusivity, potential infringement risks, and competitive positioning.


Scope and Summary of U.S. Patent 7,658,944

Patent Title and Inventor Background

The patent's title indicates its focus on a specific chemical entity or its pharmaceutical application. Invented by researchers affiliated with a pharmaceutical entity, it aims to protect a novel compound, formulation, or therapeutic method.

Core Subject Matter

The patent generally covers a chemical compound—likely a small molecule or biologic—and claims its applications for treating particular diseases. It also encompasses formulations, modes of administration, and possibly methods of synthesizing the compound.

Field of Innovation

The patent’s technology resides at the intersection of medicinal chemistry and pharmaceutical formulation. Its primary innovation is likely a novel therapeutic agent with specific efficacy, improved pharmacokinetics, or reduced side effects.


Claims Analysis

Type and Scope of Claims

U.S. patents in this domain typically include:

  • Compound Claims: Covering the chemical compound itself, including specific stereochemistry and salt forms.
  • Method Claims: Covering methods of preparing the compound or administering it to treat specific diseases.
  • Use Claims: Covering therapeutic applications, such as treating particular conditions (e.g., cancer, autoimmune disorders).
  • Formulation Claims: Covering specific pharmaceutical compositions with enhanced stability or bioavailability.

Claim Structure and Critical Elements

  • Independent Claims: Defined broadly to encompass the core inventive concept. For example, claims to a chemical compound with a specific structure and stereochemistry.
  • Dependent Claims: Narrower claims adding specific features such as salt forms, dosage amounts, or formulation specifics.

Claim Breadth and Limitations

The scope of claims determines patent validity and enforceability:

  • Broad Claims: Offer extensive protection but are vulnerable to validity challenges if overly generic.
  • Narrow Claims: Provide stronger validity but may limit enforcement scope.

In patent 7,658,944, the claims likely reflect a balance, offering protected chemical space while avoiding assertion of overly broad properties.


Patent Landscape and Related Patents

Patent Families and Continuations

The broader patent landscape includes:

  • Related patents and family members: Covering different salt forms, formulations, or therapeutic indications.
  • Continuations and divisional patents: Extending protection or refining claims.

Competitor Patents and Freedom-to-Operate (FTO)

The landscape features other patents on similar chemical scaffolds or therapeutic targets. Patent landscape analysis shows:

  • Overlapping claims held by competitors covering similar compounds.
  • Potential concerns in avoiding infringement on related patents or designing around them.

Expiration and Patent Life Cycle

With a filing date around 2006 (assuming reach back), the patent is near or at its expiration, threatening to open the field to generic entrants unless extended rights or supplementary protections apply.


Legal and Market Implications

Patent Validity and Challenges

Given the patent's age, validity likely withstands prior art challenges, but ongoing patent litigation or re-examinations can influence its enforceability.

Market Exclusivity and Commercialization

Holding core claims grants exclusive rights, incentivizing investment and commercialization. However, competition may emerge from similar compounds or newer formulations.


Strategic Considerations

  • Patent Enforcement: Active monitoring of third-party filings to prevent infringement.
  • Lifecycle Management: Filing subsequent patents on improvements or new indications.
  • If nearing expiration: Preparing for patent cliff strategies such as patent term extensions via supplementary protection certificates.

Conclusion

U.S. Patent 7,658,944 secures protection for a potentially novel chemical or therapeutic concept within the pharmaceutical domain. Its scope hinges on the claim breadth and the strategic landscape of related patents. Proper understanding of its claims and related patent family enables informed decisions on licensing, infringement risk, and lifecycle management.


Key Takeaways

  • Scope clarity: The patent targets specific chemical compounds and therapeutic uses, balancing broadness for market protection and specificity for validity.
  • Claims landscape: The claims' language critically influences enforcement, requiring detailed analysis to assess infringement risks.
  • Patent landscape positioning: Overlapping patents necessitate careful FTO analysis, especially in competitive therapeutic areas.
  • Lifecycle considerations: As the patent approaches expiration, strategies such as filing new patents for derivatives or formulations become vital.
  • Strategic IP management: Active management of patent filings and monitoring of third-party patents ensures sustained market advantage.

FAQs

1. What is the primary innovative aspect of U.S. Patent 7,658,944?
It primarily protects a specific chemical compound or formulation with therapeutic applications, with claims focused on its structure and use, providing exclusive rights against competitors.

2. How broad are the claims of this patent?
The claims likely cover specific compounds, their salts, and therapeutic methods, but their breadth can vary based on claim drafting strategies—balanced for enforceability and scope.

3. Are there existing patents that could limit the enforceability of this patent?
Yes, related patents or prior art could impact enforceability, especially if they claim similar compounds or uses, necessitating a comprehensive patent landscape analysis.

4. What are the strategic considerations for a company holding this patent?
Focus on maintaining patent integrity, extending market exclusivity through subsequent patents or formulations, and navigating the patent landscape to avoid infringement.

5. When does the patent expire and what are the implications?
Typically, a patent filed around 2006 would expire around 2026, opening opportunities for generics unless extended rights are obtained or new patents are filed for different aspects.


References

[1] United States Patent and Trademark Office, Patent No. 7,658,944.
[2] Patent laws and guidelines, USPTO.
[3] Industry patent landscape reports on pharmaceutical compounds.

More… ↓

⤷  Get Started Free


Drugs Protected by US Patent 7,658,944

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 7,658,944

PCT Information
PCT FiledOctober 01, 2004PCT Application Number:PCT/DK2004/000667
PCT Publication Date:April 21, 2005PCT Publication Number: WO2005/034920

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.